69 reports

  • HEART FAILURE DRUGS MARKET IN AMERICAS
  • HEART FAILURE DRUGS MARKET IN APAC
  • Beta-Blocker
  • Heart Failure
  • Amgen Inc.
  • AstraZeneca PLC
  • Novartis AG

Global Acute Heart Failure (AHF) Therapeutics - Pharmaceuticals I.

  • Heart Failure
  • Therapy
  • Europe
  • United States
  • World

Key Features of the Report: - Acute Heart Failure Patient Flow - Acute Heart Failure Prevalence - Acute Heart Failure Diagnosed Patients - Acute Heart Failure Treated Patients

  • Heart Failure
  • Europe
  • France
  • World
  • Forecast
  • 2 Heart Failure: Executive Summary
  • 4.1 BIBLIOGRAPHY
  • Heart Failure
  • Hospital
  • United States
  • Forecast
  • American Heart Association, Inc.
  • NYHA Classification of Heart Failure
  • Aetiologies of Heart Failure
  • Cardiovascular Disease
  • Chronic Disease
  • Heart Failure
  • Pathology
  • Europe

Key Features of the Report: - Acute Heart Failure Patient Flow - Acute Heart Failure Prevalence - Acute Heart Failure Diagnosed Patients - Acute Heart Failure Treated Patients

  • Heart Failure
  • Europe
  • France
  • Germany
  • Forecast

Acute Heart failure (AHF) -Epidemiology Forecast to 2027 ##.

  • Heart Failure
  • France
  • Germany
  • Italy
  • Spain

Acute Heart failure (AHF) : ##MM Market Analysis ##. ##. ##MM Market Size of Acute Heart failure (AHF) ##. ##. ##MM Percentage Share of drugs marketed for Acute Heart failure (AHF) ##. ##. ##MM Market Sales of Acute Heart failure (AHF) by

  • Chronic Disease
  • Heart Failure
  • IDENTIFYING FACTORS IMPACTING MARKET GROWTH
  • Market Definition
  • Heart Failure
  • Abiomed, Inc.
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Thoratec Corporation
  • 12.8.5 BUSINESS STRATEGY
  • DATE
  • Heart Failure
  • World
  • Market Size
  • Abiomed, Inc.
  • Medtronic, Inc.
  • 11.7.4 KEY DEVELOPMENTS
  • By Patient Type
  • Heart Failure
  • World
  • Market Size
  • Abbott Laboratories, Inc.
  • Abiomed, Inc.
  • TREATMENT ALTERNATIVES FOR HEART FAILURE
  • 2.1 HEART FAILURE: AN OVERVIEW
  • Heart Failure
  • HeartWare International, Inc.
  • Jude Medical, Inc.
  • ReliantHeart
  • Thoratec Corporation
  • FOCUS ON UNMET NEEDS FOR ADVANCED HEART FAILURE
  • HOSPITAL ADMISSION FOR CONGESTIVE HEART FAILURE PER 100,000 INDIVIDUALS IN FEW COUNTRIES IN EMEA 2008 AND 2013
  • Heart Failure
  • Abiomed, Inc.
  • HeartWare International, Inc.
  • Jude Medical, Inc.
  • Thoratec Corporation

How confident are you that LCZ##' s benefit will translate into heart failure patients with preserved ejection fraction?

  • Cardiovascular Drug
  • Heart Failure
  • Pharmaceutical
  • Therapy
  • Europe
  • Book on Cardiovascular and Lung Diseases. Available from:

TARGETING THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HEART FAILURE.

  • Heart Failure
  • World
  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • REVENUE OF GLOBAL BTR THERAPY IN LVAD MARKET 2015-2020 ($ MILLIONS)
  • IMPACT OF DRIVERS AND CHALLENGES
  • Heart Failure
  • World
  • Abiomed, Inc.
  • Jarvik Heart, Inc.
  • Jude Medical, Inc.

It offers CRT-Ps through the cardiac rhythm and heart failure sub-segment.

  • Heart Failure
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • LivaNova PLC
  • Medtronic, Inc.
  • Acute Heart Failure Overview
  • Acute Heart Failure - Dormant Projects
  • Heart Failure
  • Therapy
  • United States
  • World
  • Product Initiative
  • LATEST CLINICAL TRIALS NEWS ON CONGESTIVE HEART FAILURE (HEART FAILURE)
  • Among the European countries, Germany has the highest number of congestive heart failure (heart failure) clinical trials, as of June 2017.
  • Cardiovascular Disease
  • Chronic Disease
  • Clinical Trial
  • Heart Failure
  • World
  • TOP COMPANIES PARTICIPATING IN DIASTOLIC HEART FAILURE THERAPEUTICS CLINICAL TRIALS
  • PROPORTION OF DIASTOLIC HEART FAILURE TO CARDIOVASCULAR CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • Cardiology
  • Heart Failure
  • World
  • Product Initiative
  • Pfizer Inc.

Strong net sales in aortic and peripheral products with the addition of a part of Covidien' s peripheral business, and growth in cardiac rhythm & heart failure and coronary and structural heart categories attributed to the growth of the revenue.

  • Heart Failure
  • Interventional Cardiology Device
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Terumo Corporation
  • Latest Clinical Trials News on Acute Heart Failure
  • PROPORTION OF ACUTE HEART FAILURE TO CARDIOVASCULAR CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • Cardiology
  • Clinical Trial
  • Heart Failure
  • Therapy
  • Novartis AG
  • Latest Clinical Trials News on Acute Heart Failure
  • Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Heart Failure
  • Therapy
  • World
  • Product Initiative
  • Novartis AG
  • REASONS FOR DISCONTINUATION
  • CICLOMULSION LATE-PHASE TRIAL DATA IN ACUTE CORONARY SYNDROME
  • Heart Failure
  • Europe
  • AstraZeneca PLC
  • NSTEMI group
  • The Medicines Company
  • DIASTOLIC HEART FAILURE
  • Unaccomplished Trials of Diastolic Heart Failure
  • Heart Failure
  • Therapy
  • World
  • Market Size
  • Product Initiative
  • CONGESTIVE HEART FAILURE (HEART FAILURE)
  • CONGESTIVE HEART FAILURE (HEART FAILURE)
  • Cardiovascular Disease
  • Gene Therapy
  • Heart Failure
  • United States
  • Product Initiative
  • CONGESTIVE HEART FAILURE (HEART FAILURE)
  • CONGESTIVE HEART FAILURE (HEART FAILURE)
  • Cardiovascular Disease
  • Chronic Disease
  • Heart Failure
  • United States
  • Product Initiative
  • Latest Clinical Trials News on Congestive Heart Failure (Heart Failure)
  • Clinical Trials by G7 Countries: Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials
  • Cardiovascular Disease
  • Clinical Trial
  • Drug Discovery And Development
  • Heart Failure
  • World
  • Systolic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Systolic Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Cardiovascular Disease
  • Chronic Disease
  • Heart Failure
  • World
  • Product Initiative
  • EPIDEMIOLOGIC TRANSITION OF CV DISEASES
  • Heart Failure
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • GlaxoSmithKline plc